{"schema":"hottub-news/story/v1","story":"st_7hliboa3ppj4wgmnafea","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO","title_en":null,"outlets":3,"brief":null,"page":"https://hottub.news/stories/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-7hliboa3pp","count":33,"items":[{"id":"n_rem4ajrgi4lkgfcxksga","seq":926693,"kind":"article","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...","url":"https://www.pr-inside.com/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-r5228935.htm","published":"2026-09-30T14:41:57Z","seen":"2026-09-30T14:41:57Z","lang":"en","source":{"id":"pr-inside.com","name":"pr-inside.com","domain":"pr-inside.com"},"via":"gdelt-gkg-english","topics":["economy","business","health"],"story":"st_7hliboa3ppj4wgmnafea","category":"crime-law","category_p":0.47999998927116394,"category2":"economy-business","sentiment":"negative","tone":-0.44999998807907104,"political":0.15000000596046448},{"id":"n_v45zhijdtdta66gljvaq","seq":784209,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO","url":"https://www.globenewswire.com/news-release/2026/09/29/3371459/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-the-cooper-companies-inc-coo.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Cooper Companies, Inc. (“Cooper” or the “Company”) (NASDAQ: COO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T23:01:00Z","seen":"2026-09-29T23:13:49Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6200000047683716,"category2":"crime-law","sentiment":"neutral","tone":-0.33000001311302185,"political":0.14000000059604645},{"id":"n_ei7upv6yoryv73lrahta","seq":784211,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jackson Financial Inc. - JXN","url":"https://www.globenewswire.com/news-release/2026/09/29/3371457/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-jackson-financial-inc-jxn.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Jackson Financial Inc. (“Jackson Financial” or the “Company”) (NYSE: JXN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T22:45:00Z","seen":"2026-09-29T23:13:49Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.7599999904632568,"sentiment":"neutral","tone":-0.44999998807907104,"political":0.14000000059604645},{"id":"n_sbnp6qlawiwi5gwxdvdq","seq":781540,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flutter Entertainment plc - FLUT","url":"https://www.globenewswire.com/news-release/2026/09/29/3371451/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-flutter-entertainment-plc-flut.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Flutter Entertainment plc (“Flutter” or the “Company”) (NYSE: FLUT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T22:26:00Z","seen":"2026-09-29T22:41:56Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q23022611","name":"Flutter Entertainment","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.46000000834465027,"sentiment":"negative","tone":-0.41999998688697815,"political":0.03999999910593033},{"id":"n_hkhy6srqvmu26vdaks7q","seq":781541,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of lululemon athletica inc. - LULU","url":"https://www.globenewswire.com/news-release/2026/09/29/3371450/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-lululemon-athletica-inc-lulu.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of lululemon athletica inc. (“lululemon” or the “Company”) (NASDAQ: LULU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T22:25:00Z","seen":"2026-09-29T22:41:56Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q6702957","name":"Lululemon Athletica","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.36000001430511475,"category2":"crime-law","sentiment":"neutral","tone":-0.28999999165534973,"political":0.05999999865889549},{"id":"n_73uajuyljc3567dz35ya","seq":775722,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bally’s Corporation - BALY","url":"https://www.globenewswire.com/news-release/2026/09/29/3371446/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-bally-s-corporation-baly.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bally’s Corporation (“Bally’s” or the “Company”) (NYSE: BALY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T22:19:00Z","seen":"2026-09-29T22:25:17Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.7699999809265137,"sentiment":"neutral","tone":-0.38999998569488525,"political":0.18000000715255737},{"id":"n_jg2tqejn32fmtao4irda","seq":775723,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE","url":"https://www.globenewswire.com/news-release/2026/09/29/3371445/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-ultragenyx-pharmaceutical-inc-rare.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T22:15:00Z","seen":"2026-09-29T22:25:17Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.5799999833106995,"sentiment":"neutral","tone":-0.3499999940395355,"political":0.17000000178813934},{"id":"n_hl6fpnrvllo47uhghlxa","seq":773564,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of America’s Car-Mart, Inc. - CRMT","url":"https://www.globenewswire.com/news-release/2026/09/29/3371439/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-america-s-car-mart-inc-crmt.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of America’s Car-Mart, Inc. (“Car-Mart” or the “Company”) (NASDAQ: CRMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:46:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.8199999928474426,"sentiment":"neutral","tone":-0.3700000047683716,"political":0.1899999976158142},{"id":"n_dhgaeom4yftjfpjgp5ta","seq":773565,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS","url":"https://www.globenewswire.com/news-release/2026/09/29/3371438/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sellas-life-sciences-group-inc-sls.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SELLAS Life Sciences Group, Inc. (“Sellas” or the “Company”) (NASDAQ: SLS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:46:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q8012895","name":"Stanford Law School","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.5099999904632568,"sentiment":"neutral","tone":-0.20000000298023224,"political":0.05999999865889549},{"id":"n_mjg4iw5gtahmkacwxaba","seq":773568,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN","url":"https://www.globenewswire.com/news-release/2026/09/29/3371435/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-medline-inc-mdln.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:45:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q96100462","name":"Modernland Realty Ltd","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.550000011920929,"category2":"crime-law","sentiment":"neutral","tone":-0.4000000059604645,"political":0.14000000059604645},{"id":"n_av5lv6g24vit3phvz2hq","seq":773570,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO","url":"https://www.globenewswire.com/news-release/2026/09/29/3371433/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-abeona-therapeutics-inc-abeo.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:43:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6200000047683716,"sentiment":"negative","tone":-0.44999998807907104,"political":0.12999999523162842},{"id":"n_fn3stnu2uxsq337fzpba","seq":773571,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. - SEDG","url":"https://www.globenewswire.com/news-release/2026/09/29/3371432/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-solaredge-technologies-inc-sedg.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:43:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.8100000023841858,"sentiment":"neutral","tone":-0.2800000011920929,"political":0.14000000059604645},{"id":"n_j5ttucppuzwguanvsifq","seq":773572,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kinross Gold Corporation - KGC","url":"https://www.globenewswire.com/news-release/2026/09/29/3371431/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kinross-gold-corporation-kgc.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kinross Gold Corporation (“Kinross” or the “Company”) (NYSE: KGC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:42:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q546880","name":"Kinross Gold","type":"org"},{"id":"Q72948957","name":"Kysucká galéria","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.7400000095367432,"sentiment":"neutral","tone":-0.3799999952316284,"political":0.14000000059604645},{"id":"n_whhsmclouanhiyolycha","seq":773573,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA","url":"https://www.globenewswire.com/news-release/2026/09/29/3371430/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-hca-healthcare-inc-hca.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (\"HCA\" or the \"Company\") (NYSE: HCA ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:41:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q93018261","name":"Homes and Communities Agency","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.47999998927116394,"sentiment":"neutral","tone":-0.36000001430511475,"political":0.15000000596046448},{"id":"n_omtkr2dj2c2hbwuf4jsa","seq":773574,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM","url":"https://www.globenewswire.com/news-release/2026/09/29/3371426/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-beam-therapeutics-inc-beam.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Beam Therapeutics Inc. (“Beam” or the “Company”) (NASDAQ: BEAM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:39:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q2376482","name":"beam","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6200000047683716,"sentiment":"neutral","tone":-0.3499999940395355,"political":0.07999999821186066},{"id":"n_rqdhm5euqz27edc6syqa","seq":773576,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS","url":"https://www.globenewswire.com/news-release/2026/09/29/3371428/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-novartis-ag-nvs.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:39:00Z","seen":"2026-09-29T21:52:44Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q507154","name":"Novartis","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6499999761581421,"sentiment":"neutral","tone":-0.25999999046325684,"political":0.20000000298023224},{"id":"n_tyvwkhvb67xxxteuyfya","seq":771487,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EHang Holdings Limited - EH","url":"https://www.globenewswire.com/news-release/2026/09/29/3371421/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-ehang-holdings-limited-eh.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of EHang Holdings Limited (“EHang” or the “Company”) (NASDAQ: EH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:35:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6399999856948853,"sentiment":"neutral","tone":-0.36000001430511475,"political":0.18000000715255737},{"id":"n_gta77l63peyffua73cla","seq":771488,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corning Incorporated - GLW","url":"https://www.globenewswire.com/news-release/2026/09/29/3371420/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-corning-incorporated-glw.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Corning Incorporated (“Corning” or the “Company”) (NYSE: GLW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:34:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q5842736","name":"Corning Inc.","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.8399999737739563,"sentiment":"neutral","tone":-0.28999999165534973,"political":0.10000000149011612},{"id":"n_ybciebbqyfxyfhyvkehq","seq":771489,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA","url":"https://www.globenewswire.com/news-release/2026/09/29/3371419/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-tyra-biosciences-inc-tyra.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tyra Biosciences, Inc. (“Tyra” or the “Company”) (NASDAQ: TYRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:33:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q138460596","name":"Tyra Biosciences","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.5099999904632568,"sentiment":"neutral","tone":-0.20000000298023224,"political":0.14000000059604645},{"id":"n_yoxvnsy4ifhbdjg73sgq","seq":771490,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Boeing Company - BA","url":"https://www.globenewswire.com/news-release/2026/09/29/3371418/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-the-boeing-company-ba.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Boeing Company (“Boeing” or the “Company”) (NYSE: BA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:32:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.800000011920929,"sentiment":"neutral","tone":-0.3700000047683716,"political":0.3799999952316284},{"id":"n_7fcah56hx46zemc7h63q","seq":771491,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS","url":"https://www.globenewswire.com/news-release/2026/09/29/3371417/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-cellectis-s-a-clls.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellectis S.A. (“Cellectis” or the “Company”) (NASDAQ: CLLS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:32:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6299999952316284,"sentiment":"neutral","tone":-0.27000001072883606,"political":0.10000000149011612},{"id":"n_4gccrm5bxidvy7kq7hyq","seq":771494,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD","url":"https://www.globenewswire.com/news-release/2026/09/29/3371414/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-acadia-pharmaceuticals-inc-acad.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:29:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q4671580","name":"Acadia Pharmaceuticals","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.5899999737739563,"sentiment":"neutral","tone":-0.3199999928474426,"political":0.14000000059604645},{"id":"n_vjj7bn5pdc7qc4wwr6gq","seq":771496,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT","url":"https://www.globenewswire.com/news-release/2026/09/29/3371412/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-cellebrite-di-ltd-clbt.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:26:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6399999856948853,"sentiment":"neutral","tone":-0.27000001072883606,"political":0.10999999940395355},{"id":"n_zisyehcck44zlc4y57rq","seq":771502,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION","url":"https://www.globenewswire.com/news-release/2026/09/29/3371406/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sionna-therapeutics-inc-sion.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sionna Therapeutics, Inc. (“Sionna” or the “Company”) (NASDAQ: SION). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:22:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.550000011920929,"sentiment":"neutral","tone":-0.4000000059604645,"political":0.1599999964237213},{"id":"n_hsapr2eimruipxn5kqnq","seq":771505,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Children’s Place, Inc. - PLCE","url":"https://www.globenewswire.com/news-release/2026/09/29/3371404/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-the-children-s-place-inc-plce.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Children’s Place, Inc. (“The Children’s Place” or the “Company”) (NASDAQ: PLCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:20:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6100000143051147,"sentiment":"neutral","tone":-0.30000001192092896,"political":0.11999999731779099},{"id":"n_zwozgjab725erbgsmsra","seq":771506,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS","url":"https://www.globenewswire.com/news-release/2026/09/29/3371402/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-osi-systems-inc-osis.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:20:00Z","seen":"2026-09-29T21:36:52Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6000000238418579,"sentiment":"neutral","tone":-0.3199999928474426,"political":0.15000000596046448},{"id":"n_aydupfpudtacplfcc6ya","seq":770046,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ","url":"https://www.globenewswire.com/news-release/2026/09/29/3371400/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-lenz-therapeutics-inc-lenz.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. (“Lenz” or the “Company”) (NASDAQ: LENZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:19:00Z","seen":"2026-09-29T21:20:21Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q139917457","name":"LENZ THERAPEUTICS, INC.","type":"org"},{"id":"Q65957951","name":"Lenz","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.5899999737739563,"sentiment":"neutral","tone":-0.33000001311302185,"political":0.07999999821186066},{"id":"n_5h6r43c7cdthufirzyta","seq":770049,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NuScale Power Corporation - SMR","url":"https://www.globenewswire.com/news-release/2026/09/29/3371396/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nuscale-power-corporation-smr.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:15:00Z","seen":"2026-09-29T21:20:21Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q238","name":"San Marino","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.7300000190734863,"sentiment":"neutral","tone":-0.4300000071525574,"political":0.23000000417232513},{"id":"n_jofs6jhlvhe7clskvyba","seq":770060,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL","url":"https://www.globenewswire.com/news-release/2026/09/29/3371387/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-anavex-life-sciences-corp-avxl.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T21:03:00Z","seen":"2026-09-29T21:20:21Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q67766547","name":"Anavex Life Sciences Corp.","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.6399999856948853,"sentiment":"neutral","tone":-0.28999999165534973,"political":0.10000000149011612},{"id":"n_2aw7o7tk4sfbkqbn63wq","seq":772245,"kind":"article","title":"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment ...","url":"http://www.gazettextra.com/news/nation_world/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment/article_ed7f205f-0a5e-5235-a74f-69434d23ce71.html","published":"2026-09-29T21:00:00Z","seen":"2026-09-29T21:46:54Z","lang":"en","source":{"id":"gazettextra.com","name":"gazettextra.com","domain":"gazettextra.com","outlet":{"wikidata":"Q55671441","name":"Janesville Gazette","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","business"],"authors":["Pomerantz LLP - (GLOBE NEWSWIRE)"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.699999988079071,"sentiment":"negative","tone":-0.6100000143051147,"political":0.07999999821186066},{"id":"n_4hpq2wj2zxsaeehusvnq","seq":773362,"kind":"article","title":"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ...","url":"http://www.gazettextra.com/news/nation_world/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in/article_8b4b4c17-acef-5242-bb43-c8608230b2a3.html","published":"2026-09-29T20:50:00Z","seen":"2026-09-29T21:46:54Z","lang":"en","source":{"id":"gazettextra.com","name":"gazettextra.com","domain":"gazettextra.com","outlet":{"wikidata":"Q55671441","name":"Janesville Gazette","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","business"],"authors":["Pomerantz LLP - (GLOBE NEWSWIRE)"],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.7099999785423279,"sentiment":"negative","tone":-0.6000000238418579,"political":0.10000000149011612},{"id":"n_gwp2esud2rla3ptptpoq","seq":765851,"kind":"press_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endava plc - DAVA","url":"https://www.globenewswire.com/news-release/2026/09/29/3371370/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-endava-plc-dava.html","summary":"NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Endava plc (“Endava” or the “Company”) (NYSE: DAVA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.","published":"2026-09-29T20:47:00Z","seen":"2026-09-29T20:48:56Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q12727645","name":"Endava","type":"org"}],"story":"st_7hliboa3ppj4wgmnafea","category":"economy-business","category_p":0.699999988079071,"sentiment":"neutral","tone":-0.27000001072883606,"political":0.27000001072883606},{"id":"n_7hliboa3ppj4wgmnafea","seq":539787,"kind":"article","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...","url":"https://www.pr-inside.com/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-r5228333.htm","published":"2026-09-28T23:09:12Z","seen":"2026-09-28T23:09:12Z","lang":"en","source":{"id":"pr-inside.com","name":"pr-inside.com","domain":"pr-inside.com"},"via":"gdelt-gkg-english","topics":["economy","business"],"story":"st_7hliboa3ppj4wgmnafea","category":"crime-law","category_p":0.47999998927116394,"category2":"economy-business","sentiment":"negative","tone":-0.47999998927116394,"political":0.15000000596046448}]}